MRNA is expected to report earnings to rise 6.19% to -308 cents per share on May 01
Q1'25
Est.
$-3.09
Q4'24
Missed
by $0.18
Q3'24
Beat
by $1.95
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.48
The last earnings report on February 14 showed earnings per share of -291 cents, missing the estimate of -273 cents. With 11.68M shares outstanding, the current market capitalization sits at 10.72B.